TREDJE AP-FONDEN – Regeneron Pharmaceuticals, Inc. Transaction History
TREDJE AP-FONDEN portfolio value:
$18.08M
portfolio value
TREDJE AP-FONDEN quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +189.95% | 17.19K shares | 12.72M | $688.87 | 26.24K |
| Q2 2022 | share | 0.00% | 0 shares | -971K | $591.13 | 9.05K | |
| Q1 2022 | share | 0.00% | 0 shares | 605K | $698.42 | 9.05K | |
| Q4 2021 | share | 0.00% | 0 shares | 239K | $642.51 | 9.05K | |
| Q3 2021 | share | 0.00% | 0 shares | 422K | $605.18 | 9.05K | |
| Q2 2021 | share | 0.00% | 0 shares | 773K | $558.54 | 9.05K | |
| Q1 2021 | share | 0.00% | 0 shares | -90K | $473.14 | 9.05K | |
| Q4 2020 | share | 0.00% | 0 shares | -694K | $483.11 | 9.05K | |
| Q3 2020 | share | 0.00% | 0 shares | -578K | $559.78 | 9.05K | |
| Q2 2020 | share | Decrease | -40.55% | -6.17K shares | -1.79M | $623.65 | 9.05K |
| Q1 2020 | share | Decrease | -3.31% | -521 shares | 1.52M | $488.29 | 15.22K |
| Q4 2019 | share | Decrease | -5.67% | -946 shares | 1.28M | $375.48 | 15.74K |
| Q3 2019 | share | Increase | +0.71% | 118 shares | -557K | $277.4 | 16.69K |
| Q2 2019 | share | Increase | +4.68% | 741 shares | -1.31M | $313 | 16.57K |
| Q1 2019 | share | Increase | +7.21% | 1.06K shares | 986K | $410.62 | 15.83K |
| Q4 2018 | share | Decrease | -40.85% | -10.2K shares | -4.57M | $373.5 | 14.76K |
| Q3 2018 | share | Decrease | -9.30% | -2.55K shares | 591K | $404.04 | 24.96K |
| Q2 2018 | share | Increase | +5.48% | 1.43K shares | 510K | $344.99 | 27.52K |
| Q1 2018 | share | Increase | +3.08% | 779 shares | -532K | $344.36 | 26.09K |
| Q4 2017 | share | Decrease | -0.20% | -50 shares | -1.82M | $375.96 | 25.31K |
| Q3 2017 | share | Increase | +3.21% | 790 shares | -729K | $447.12 | 25.36K |
| Q2 2017 | share | Decrease | -0.45% | -110 shares | 2.50M | $491.14 | 24.57K |
| Q1 2017 | share | Increase | +0.18% | 44 shares | 520K | $387.51 | 24.68K |
| Q4 2016 | share | Decrease | -0.79% | -196 shares | -940K | $367.09 | 24.64K |
| Q3 2016 | share | Decrease | -2.96% | -759 shares | 1.04M | $402.02 | 24.84K |
| Q2 2016 | share | Increase | +0.02% | 5 shares | -578K | $349.23 | 25.6K |
| Q1 2016 | share | Increase | +9.09% | 2.13K shares | -3.21M | $360.44 | 25.59K |